NEO Foundation Denies Insider Trading Claims as Token Prices Experience 35% Drop Amidst Investigation
NEO Foundation Denies Insider Trading Claims as Token Prices Experience 35% Drop Amidst Investigation
NEO slumps 35%: Foundation denies sell-off, probes massive Binance transfers
Why more investors are choosing Zig Network over DOGE, ETC, NEO
Is NEO The One? New Crypto Casino King Has Huge Early Presale Interest From BNB Backers Wanting Big Returns
NEO Provides a Platform for Decentralized Applications
962.64MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US64049M2098
CUSIP
64049M209
Sector
Healthcare
Industry
Diagnostics & Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
3.02
Book Value
6.92
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.61
Wall Street Target Price
11.25
EPS Estimate Current Year
0.16
EPS Estimate Next Year
0.31
EPS Estimate Current Quarter
-0.01
EPS Estimate Next Quarter
0.0482
Most Recent Quarter
-
Revenue TTM
672,361,024
Gross Profit TTM
297,876,992
EBITDA
657,000
Profit Margin
-11.54%
Return On Assets TTM
-2.75%
Return On Equity TTM
-8.57%
Revenue Per Share TTM
5.295
Qtly Revenue Growth YOY
7.50%
Diluted Eps TTM
-0.61
Qtly Earnings Growth YOY
130.60%
Trailing PE
0.00
Forward PE
222
Price Sales TTM
1.4317
Price Book MRQ
1.0837
Enterprise Value Revenue
1
Enterprise Value EBITDA
-27
9.34
3.35%689.45
2.44%115.05
2.00%1169.67
0.28%167.52
0.23%404.40
0.20%68.61
0.18%148.00
0.10%525.01
0.01%193.05
-0.02%